325 related articles for article (PubMed ID: 30711569)
1. LncRNA MEG3 functions as a ceRNA in regulating hepatic lipogenesis by competitively binding to miR-21 with LRP6.
Huang P; Huang FZ; Liu HZ; Zhang TY; Yang MS; Sun CZ
Metabolism; 2019 May; 94():1-8. PubMed ID: 30711569
[TBL] [Abstract][Full Text] [Related]
2. LncRNA-H19 promotes hepatic lipogenesis by directly regulating miR-130a/PPARγ axis in non-alcoholic fatty liver disease.
Liu J; Tang T; Wang GD; Liu B
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31064820
[No Abstract] [Full Text] [Related]
3. miR-122 promotes hepatic lipogenesis via inhibiting the LKB1/AMPK pathway by targeting Sirt1 in non-alcoholic fatty liver disease.
Long JK; Dai W; Zheng YW; Zhao SP
Mol Med; 2019 Jun; 25(1):26. PubMed ID: 31195981
[TBL] [Abstract][Full Text] [Related]
4. LncRNA Gm28382 promotes lipogenesis by interacting with miR-326-3p to regulate ChREBP signaling pathway in NAFLD.
Yang S; Zhang Y; Zhang Y; Yin L; Han X; Zhao X; Wang N; Xu L
Int Immunopharmacol; 2024 Jan; 127():111444. PubMed ID: 38157698
[TBL] [Abstract][Full Text] [Related]
5. Lycopus lucidus Turcz. ex Benth. Attenuates free fatty acid-induced steatosis in HepG2 cells and non-alcoholic fatty liver disease in high-fat diet-induced obese mice.
Lee MR; Yang HJ; Park KI; Ma JY
Phytomedicine; 2019 Mar; 55():14-22. PubMed ID: 30668424
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA AC012668 suppresses non-alcoholic fatty liver disease by competing for microRNA miR-380-5p with lipoprotein-related protein LRP2.
Chen X; Ma H; Gao Y; Jin Y; Ning W; Hou Y; Su J
Bioengineered; 2021 Dec; 12(1):6738-6747. PubMed ID: 34511037
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of miR-192 causes hepatic steatosis and lipid accumulation by inducing SREBF1: Novel mechanism for bisphenol A-triggered non-alcoholic fatty liver disease.
Lin Y; Ding D; Huang Q; Liu Q; Lu H; Lu Y; Chi Y; Sun X; Ye G; Zhu H; Wei J; Dong S
Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Sep; 1862(9):869-882. PubMed ID: 28483554
[TBL] [Abstract][Full Text] [Related]
8. High-content hydrogen water-induced downregulation of miR-136 alleviates non-alcoholic fatty liver disease by regulating Nrf2 via targeting MEG3.
Wang X; Wang J
Biol Chem; 2018 Mar; 399(4):397-406. PubMed ID: 29261513
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA lncARSR promotes hepatic lipogenesis via Akt/SREBP-1c pathway and contributes to the pathogenesis of nonalcoholic steatohepatitis.
Zhang M; Chi X; Qu N; Wang C
Biochem Biophys Res Commun; 2018 Apr; 499(1):66-70. PubMed ID: 29555473
[TBL] [Abstract][Full Text] [Related]
10. miR-212 downregulation contributes to the protective effect of exercise against non-alcoholic fatty liver via targeting FGF-21.
Xiao J; Bei Y; Liu J; Dimitrova-Shumkovska J; Kuang D; Zhou Q; Li J; Yang Y; Xiang Y; Wang F; Yang C; Yang W
J Cell Mol Med; 2016 Feb; 20(2):204-16. PubMed ID: 26648452
[TBL] [Abstract][Full Text] [Related]
11. miR-149 controls non-alcoholic fatty liver by targeting FGF-21.
Xiao J; Lv D; Zhao Y; Chen X; Song M; Liu J; Bei Y; Wang F; Yang W; Yang C
J Cell Mol Med; 2016 Aug; 20(8):1603-8. PubMed ID: 27061435
[TBL] [Abstract][Full Text] [Related]
12. LncRNA NEAT1 promotes hepatic lipid accumulation via regulating miR-146a-5p/ROCK1 in nonalcoholic fatty liver disease.
Chen X; Tan XR; Li SJ; Zhang XX
Life Sci; 2019 Oct; 235():116829. PubMed ID: 31484042
[TBL] [Abstract][Full Text] [Related]
13. miR-32-5p induces hepatic steatosis and hyperlipidemia by triggering de novo lipogenesis.
Wang YD; Wu LL; Mai YN; Wang K; Tang Y; Wang QY; Li JY; Jiang LY; Liao ZZ; Hu C; Wang YY; Liu JJ; Liu JH; Xiao XH
Metabolism; 2023 Sep; 146():155660. PubMed ID: 37451670
[TBL] [Abstract][Full Text] [Related]
14. Ultraconserved element uc.372 drives hepatic lipid accumulation by suppressing miR-195/miR4668 maturation.
Guo J; Fang W; Sun L; Lu Y; Dou L; Huang X; Tang W; Yu L; Li J
Nat Commun; 2018 Feb; 9(1):612. PubMed ID: 29426937
[TBL] [Abstract][Full Text] [Related]
15. Mesencephalic astrocyte-derived neurotrophic factor ameliorates steatosis in HepG2 cells by regulating hepatic lipid metabolism.
He M; Wang C; Long XH; Peng JJ; Liu DF; Yang GY; Jensen MD; Zhang LL
World J Gastroenterol; 2020 Mar; 26(10):1029-1041. PubMed ID: 32205994
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-122 Inhibits Lipid Droplet Formation and Hepatic Triglyceride Accumulation via Yin Yang 1.
Wu GY; Rui C; Chen JQ; Sho E; Zhan SS; Yuan XW; Ding YT
Cell Physiol Biochem; 2017; 44(4):1651-1664. PubMed ID: 29216638
[TBL] [Abstract][Full Text] [Related]
17. Circ_0057558 promotes nonalcoholic fatty liver disease by regulating ROCK1/AMPK signaling through targeting miR-206.
Chen X; Tan QQ; Tan XR; Li SJ; Zhang XX
Cell Death Dis; 2021 Aug; 12(9):809. PubMed ID: 34446693
[TBL] [Abstract][Full Text] [Related]
18. LncRNA GAS5 Knockdown Mitigates Hepatic Lipid Accumulation
Xu S; Wang Y; Li Z; Hua Q; Jiang M; Fan X
Front Endocrinol (Lausanne); 2022; 13():889858. PubMed ID: 35957809
[TBL] [Abstract][Full Text] [Related]
19. Acetylation of H3K27 activated lncRNA NEAT1 and promoted hepatic lipid accumulation in non-alcoholic fatty liver disease via regulating miR-212-5p/GRIA3.
Hu MJ; Long M; Dai RJ
Mol Cell Biochem; 2022 Jan; 477(1):191-203. PubMed ID: 34652536
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of miR-125b by estrogen protects against non-alcoholic fatty liver in female mice.
Zhang ZC; Liu Y; Xiao LL; Li SF; Jiang JH; Zhao Y; Qian SW; Tang QQ; Li X
J Hepatol; 2015 Dec; 63(6):1466-75. PubMed ID: 26272872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
